美股新聞 標題聯播 · 近 24 小時 348 則 · 31 個來源 · 最新 9/20 04:16
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · HTFL近 30 天 5 則 · 第 1 / 1 頁
- BCSM Exits Heartflow (HTFL) on Competitive Concerns
- HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High
- HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High
- Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half
- Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference
- HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?
- Heartflow (HTFL) Rockets 46%: What Analysts Say and Where Hedge Funds Stand
- Is HeartFlow (HTFL) Already Overvalued Or Still Worth The Hype?
- HeartFlow (HTFL) Jumps On Q2 Results As Raised Outlook Leaves Shares Fully Valued
- HeartFlow (HTFL) Stock Gets Fair Value Boost After Q2 Beat And Guidance Raise
- Analysts Are Bullish on Heartflow (HTFL) Stock. Here’s Why
- Why Heartflow Stock Soared Today
- This AI-Tied IPO Stock Just Broke Out On Its 'Outsized' Guidance Boost
- Heartflow, Inc. Common Stock Q2 2026 Earnings Call Summary
- HeartFlow Inc (HTFL) (Q2 2026) Earnings Call Highlights: Revenue Surges 48% and Plaque Momentum ...
- Heartflow Q2 Earnings Call Highlights
- HeartFlow (HTFL) Reports Q2 Loss, Beats Revenue Estimates
- Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
- Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates
- Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。